Earth Science Tech (OTCQB: ETST), a strategic holding company operating across healthcare, pharmacy, technology, telemedicine, real estate, and consumer products, is leveraging artificial intelligence and a focused IT infrastructure to drive sustainable growth and long-term value. The company’s dedicated IT department, led by Chief Technology Officer Chris Rose, has enabled it to cut costs, improve operational efficiencies, and expand profit margins within its pharmacy and telemedicine platforms. According to Rose, these benefits stem from a deliberate strategy to build technology in-house rather than purchasing third-party solutions, augmented by AI. “We build now instead of buy, supported by advancements in and our leverage of AI,” Rose said during the recent Annual Meeting of Shareholders. “We’ve built our own ETST-wide software and data platform that ties together the three pharmacies, our curative telehealth business, and My Online Consultation doctor’s” services, he added, highlighting how the integrated platform streamlines operations across the company’s diverse business lines.
The implications of this technology-first approach extend beyond internal cost savings. By developing its own software and data platform, ETST has not only improved its own margins but also created a scalable asset that can be offered to other clinics as a white-label service. This opens a new revenue stream for the company, positioning it as a technology provider in the healthcare space, not just a service operator. The move reflects a broader trend where healthcare companies are investing in proprietary technology to differentiate themselves and capture value beyond traditional service delivery.
ETST also utilizes technology in its marketing efforts to increase patient and customer retention and drive brand loyalty. By leveraging data analytics and AI-driven tools, the company can personalize outreach and improve engagement, which is critical in the competitive telemedicine and pharmacy markets. These efforts are designed to build lasting relationships with patients and customers, ultimately supporting sustainable growth.
The company’s focus on technology and innovation has been highlighted by BioMedWire, a specialized communications platform that covers developments in the biotechnology, biomedical sciences, and life sciences sectors. In a recent release, BioMedWire noted that ETST’s tech stack and developments have enabled it to offer its in-house tools to other clinics as a white-label service. The full story is available at Read More>>.
For investors, ETST’s technology strategy could translate into improved financial performance and a stronger competitive position. By controlling its own technology, the company can adapt quickly to market changes, reduce dependency on external vendors, and potentially license its platform to other healthcare providers. This aligns with the company’s goal of ensuring long-term value and sustainable growth. The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST.
BioMedWire is one of 75+ brands within the Dynamic Brand Portfolio at IBN, which delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution to millions of followers, and a full array of tailored corporate communications solutions. This infrastructure helps companies like ETST reach a wide audience of investors, influencers, and the general public. For more information, visit https://www.BioMedWire.com, and see full terms of use and disclaimers at https://www.BioMedWire.com/Disclaimer.
